
Publication
Government of Alberta launches nuclear energy engagement
On August 25, 2025, the Government of Alberta publicly re-affirmed its interest in nuclear energy with the launch of its Nuclear Energy Engagement (the Engagement).
United Kingdom | Publication | February 2025
On 24 February 2025, the Arbitration Act 2025 (the 2025 Act) received Royal Assent, and it came into force on 1 August 2025. The 2025 Act inserts a number of amendments into the Arbitration Act 1996 with the aim of modernising the Arbitration Act 1996 in order to enhance the status of England and Wales as a leading international forum for dispute resolution. The reforms follow modernisation efforts by other popular arbitration forums, including Hong Kong and Singapore, and aim to ensure London’s competitiveness as a seat for international arbitrations.
This article summarises the key reforms and their practical implications for contract drafting and arbitral procedure.
The reforms in the 2025 Act came into force on 1 August 2025.
The 2025 Act is the product of recommendations made by the Law Commission designed to promote England and Wales’s status as a world leading destination for commercial arbitration. The key reforms include:1
As stated in the Government’s press release here the new law is intended to re-enforce England and Wales’s status as the “global destination of choice for the legal sector”. The new law “makes arbitration fairer and more efficient by simplifying procedures to reduce costs and protecting arbitrators from unreasonable lawsuits. It also strengthens the courts’ powers to support emergency arbitration so time-sensitive decisions can be made more easily.” 3
The changes introduced by the 2025 Act are relatively limited “mindful of the consensus that the [Arbitration Act 1996] works well, and that root and branch reform is not needed or wanted”4. However, there are some important practical implications which include:
Publication
On August 25, 2025, the Government of Alberta publicly re-affirmed its interest in nuclear energy with the launch of its Nuclear Energy Engagement (the Engagement).
Publication
Shifting geopolitical dynamics have seen a wave of changes across the international investigations and enforcement landscape. In this edition, we focus on some of the most significant of these changes – from the issue of new cooperation guidelines by the Serious Fraud Office (SFO) to the abandonment by the Financial Conduct Authority (FCA) of its proposal to “name and shame” those it is investigating.
Publication
Health Canada has proposed a major change to the regulation of biosimilar drugs that may accelerate biologic patent litigation in Canada. Following the lead of other jurisdictions, Health Canada has proposed that biosimilar manufacturers no longer be required to conduct phase 3 clinical trials to enter the Canadian market.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025